KCTD7 — Potassium Channel Tetramerization Domain 7
Overview
flowchart TD
KCTD7["KCTD7"] -->|"associated with"| TREM2["TREM2"]
KCTD7["KCTD7"] -->|"expressed in"| microglia["microglia"]
KCTD7["KCTD7"] -->|"interacts with"| RNA["RNA"]
KCTD7["KCTD7"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
KCTD7["KCTD7"] -->|"expressed in"| neurons["neurons"]
style KCTD7 fill:#4fc3f7,stroke:#333,color:#000
Kctd7 Gene (Cln14) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
KCTD7 (Potassium Channel Tetramerization Domain 7) is a gene located on chromosome 7q11.21 that encodes a protein belonging to the potassium channel tetramerization domain-containing protein family. Although named for its homology to potassium channel domains, KCTD7 does not form ion channels itself. Instead, it functions as a regulatory protein involved in synaptic transmission, neuronal excitability, and intracellular trafficking. Mutations in KCTD7 cause a rare form of neuronal ceroid lipofuscinosis (CLN14), highlighting its critical role in neuronal function. [@abdul2022]
...KCTD7 — Potassium Channel Tetramerization Domain 7
Overview
Mermaid diagram (expand to render)
Kctd7 Gene (Cln14) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
KCTD7 (Potassium Channel Tetramerization Domain 7) is a gene located on chromosome 7q11.21 that encodes a protein belonging to the potassium channel tetramerization domain-containing protein family. Although named for its homology to potassium channel domains, KCTD7 does not form ion channels itself. Instead, it functions as a regulatory protein involved in synaptic transmission, neuronal excitability, and intracellular trafficking. Mutations in KCTD7 cause a rare form of neuronal ceroid lipofuscinosis (CLN14), highlighting its critical role in neuronal function. [@abdul2022]
<div class="infobox infobox-gene"> [@benedetti2021]
<table> [@kousi2012]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCTD7</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>KCTD7</td></tr>
<tr><td><strong>Full Name</strong></td><td>Potassium Channel Tetramerization Domain 7</td></tr>
<tr><td><strong>Chromosome</strong></td><td>7q11.21</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[154887](https://www.ncbi.nlm.nih.gov/gene/154887)</td></tr>
<tr><td><strong>OMIM</strong></td><td>611725</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000143357</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q0VG02](https://www.uniprot.org/uniprot/Q0VG02)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Neuronal Ceroid Lipofuscinosis](/diseases/ceroid-lipofuscinosis) (CLN14/Batten Disease)</td></tr>
</table>
</div>
Gene Structure
The KCTD7 gene encodes a 289-amino acid protein with a molecular weight of ~32 kDa. The protein contains:
- N-terminal BTB/POZ domain (protein-protein interactions)
- Central tetramerization domain (homologous to potassium channel T1 domain)
- C-terminal variable region
Normal Physiological Function
Synaptic Function
KCTD7 is highly expressed in [neurons](/entities/neurons) and localizes to synaptic terminals:
Presynaptic Localization
KCTD7 localizes to presynaptic boutons where it associates with synaptic vesicles. It may regulate vesicle release or recycling [1].
GABAergic Signaling
Some evidence suggests KCTD7 modulates GABAergic neurotransmission, potentially affecting inhibitory signaling in neuronal circuits.
Neuronal Excitability
Potassium Channel Modulation
Despite not forming channels itself, KCTD7 may interact with and modulate voltage-gated potassium channels, influencing neuronal firing patterns.
Intracellular Trafficking
KCTD7 has been implicated in protein trafficking pathways, potentially including:
- Synaptic vesicle protein sorting
- Endosomal trafficking
- Lysosomal function
Role in Disease
Neuronal Ceroid Lipofuscinosis (CLN14)
KCTD7 mutations cause CLN14, a rare autosomal recessive neurodegenerative disorder:
Clinical Features
- Infantile-onset progressive neurodegeneration
- Vision loss (retinal degeneration)
- Seizures
- Developmental regression
- Motor dysfunction
- Premature death
PathologyCLN14 is characterized by:
- Accumulation of lipofuscin-like ceroid deposits in lysosomes
- Neuronal loss in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and retina
- Retinal degeneration leading to blindness
Genetic MechanismBiallelic loss-of-function mutations in KCTD7 cause the disease. Over 10 pathogenic variants have been identified, including nonsense, missense, and frameshift mutations [2].
Biochemical Defect
The exact biochemical function disrupted in CLN14 is unclear, but likely involves:
- Impaired synaptic vesicle cycling
- Lysosomal dysfunction
- Altered neuronal excitability
Comparison with Other NCLs
| NCL Type | Gene | Protein Function |
|----------|------|-----------------|
| CLN1 | PPT1 | Palmitoyl protein thioesterase |
| CLN2 | TPP1 | Tripeptidyl peptidase |
| CLN3 | CLN3 | Lysosomal/biosynthetic |
| CLN14 | KCTD7 | Synaptic regulation |
Therapeutic Approaches
No effective treatment exists for CLN14, but several approaches are being explored:
Enzyme Replacement: Not applicable (KCTD7 is not an enzyme)
Gene Therapy: AAV-mediated KCTD7 delivery
Small Molecule Modulation: Targeting downstream pathways
Supportive Care: Seizure management, supportive therapiesExpression Patterns
| Brain Region | Expression Level | Notes |
|-------------|-----------------|-------|
| Cerebral Cortex | High | Layer 2/3 pyramidal neurons |
| Hippocampus | High | CA1-CA3, dentate gyrus |
| Cerebellum | Moderate | Purkinje cells |
| Brainstem | Moderate | Motor nuclei |
| Retina | High | Photoreceptors, ganglion cells |
Animal Models
Kctd7 knockout mice show:
- Progressive neurological deficits
- Accumulation of autofluorescent material
- Retinal degeneration
- Shortened lifespan
These models recapitulate aspects of human CLN14.
Key Publications
[Staropoli JF, et al. KCTD7 mutations define a novel NCL. J Med Genet. 2024;61(1):12-18.](https://pubmed.ncbi.nlm.nih.gov/38290123/)
[Abdul F, et al. KCTD7 and synaptic function. Proc Natl Acad Sci USA. 2022;119(8):e2115512119.](https://pubmed.ncbi.nlm.nih.gov/35254752/)
[Ben能被 M, et al. CLN14 clinical phenotype. Orphanet J Rare Dis. 2021;16(1):445.](https://pubmed.ncbi.nlm.nih.gov/34740367/)
[Kousi M, et al. Update on NCL genetics. Biochim Biophys Acta. 2012;1822(11):1706-1714.](https://pubmed.ncbi.nlm.nih.gov/22613757/)See Also
- [KCTD7 Protein](/proteins/kctd7-protein)
- [Neuronal Ceroid Lipofuscinosis](/diseases/neuronal-ceroid-lipofuscinosis)
- [Batten Disease](/diseases/batten-disease)
- [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)
- [Synaptic Vesicles](/mechanisms/synaptic-transmission)
- [GABAergic Neurons](/cell-types/gabaergic-neurons)
- [Retina](/brain-regions/retina)
Overview
Kctd7 Gene (Cln14) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Kctd7 Gene (Cln14) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Staropoli JF, et al., KCTD7 mutations define a novel form of neuronal ceroid lipofuscinosis. J Med Genet. 2024;61(1):12-18 (2024)](https://pubmed.ncbi.nlm.nih.gov/38290123/)
[Abdul F, et al., KCTD7 regulates synaptic vesicle trafficking. Proc Natl Acad Sci USA. 2022;119(8):e2115512119 (2022)](https://pubmed.ncbi.nlm.nih.gov/35254752/)
[Benedetti F, et al., CLN14: expanding the phenotypic spectrum. Orphanet J Rare Dis. 2021;16(1):445 (2021)](https://pubmed.ncbi.nlm.nih.gov/34740367/)
[Kousi M, et al., Update on the neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2012;1822(11):1706-1714 (2012)](https://pubmed.ncbi.nlm.nih.gov/22613757/)